Outpatient Parenteral Antimicrobial Therapy For A Diabetic Patient With A Foot Infection CME/CE

Author Information and Disclosures

Release Date: June 27, 2008; Valid for credit through June 27, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs)

The content of this CME/CE activity, “Outpatient Parenteral Antimicrobial Therapy For A Diabetic Patient With A Foot Infection,” was developed by the faculty for release on Medscape.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 The University of Wisconsin Board of Regents, University of Wisconsin-Madison School of Pharmacy and CME Enterprise
Wyeth
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify patients for whom home infusion is most appropriate and those for whom home infusion should not be an option.
  2. Choose appropriate antimicrobial agents based on culture data and outpatient parenteral antimicrobial therapy (OPAT) guidelines.
  3. Select the vascular access device that is compatible with specific antimicrobials.
  4. Use OPAT guidelines to appropriately manage antimicrobial infusion before and during OPAT.
  5. Develop a strategy to encourage and maintain critical team communications.
Authors and Disclosures

Alan D. Tice, MD, FACP, FIDSA
Disclosure: Grant/Research Support, Consultant, Advisory Board; Speakers' Bureau, and/or Honoraria: Astellas Pharma, Cubist Pharmaceuticals, Human Genome Sciences, Pfizer, Merck & Co., Replidyne


Antoinette Neal, RN, CRNI
Disclosure: Ms Neal has no relevant relationships to disclose in regard to this activity.


Joseph A. Paladino, PharmD, FCCP
Disclosure: Consultant, Advisory Board, Speakers' Bureau, and/or Honoraria: Cubist Pharmaceuticals, Schering-Plough, Forest Pharmaceuticals, Wyeth


Nasia Safdar, MD, MS
Disclosure: Dr Safdar has no relevant relationships to disclose in regard to this activity.


Anthony H. Choi, PhD
Disclosure: Dr Choi has no relevant relationships to disclose in regard to this activity.
 
The University of Wisconsin School of Medicine and Public Health
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Wisconsin School of Medicine and Public Health and CME Enterprise. The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

The University of Wisconsin School of Medicine and Public Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

ACPE logoExtension Services in Pharmacy at the University of Wisconsin-Madison School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity has been approved for a maximum of 1 hour (0.1 CEUs) of pharmacy continuing education credit. A Statement of Credit will be issued online following successful completion of this program (completion of a program evaluation and a post-test with a minimum score of 70%).

Universal program #073-999-08-084-H01-P.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity, University of Wisconsin-Madison School of Pharmacy by calling the CE office (ie, Extension Services in Pharmacy) directly by phone at 608.262.3130 or by e-mail at cemail@pharmacy.wisc.edu.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.